Stereotactic body radiotherapy for early-stage non-small cell lung cancer: clinical outcomes from a National Patient Registry
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1948-7908
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Stereotactic body radiotherapy for early-stage non-small cell lung cancer: clinical outcomes from a National Patient Registry ; volume:4 ; number:1 ; day:31 ; month:1 ; year:2015 ; pages:55-63 ; date:3.2015
Journal of radiation oncology ; 4, Heft 1 (31.1.2015), 55-63, 3.2015
- Urheber
-
Davis, Joanne N.
Medbery, Clinton
Sharma, Sanjeev
Perry, David
Pablo, John
D’Ambrosio, David J.
McKellar, Heidi
Kimsey, Frank C.
Chomiak, Paul N.
Mahadevan, Anand
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s13566-014-0177-0
- URN
-
urn:nbn:de:101:1-2019102723572711727698
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Davis, Joanne N.
- Medbery, Clinton
- Sharma, Sanjeev
- Perry, David
- Pablo, John
- D’Ambrosio, David J.
- McKellar, Heidi
- Kimsey, Frank C.
- Chomiak, Paul N.
- Mahadevan, Anand
- SpringerLink (Online service)
Ähnliche Objekte (12)
Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch® patient registry
Cost-effectiveness of stereotactic body radiotherapy versus conventional fractionated radiotherapy for medically inoperable, early-stage non-small cell lung cancer
Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer
Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer
Stereotactic ablative radiotherapy for early-stage lung cancer following double lung transplantation
Systematic review of economic evaluations on stereotactic ablative radiotherapy (SABR) compared to other radiotherapy techniques or surgical procedures for early-stage non-small cell lung cancer
Multi-omics integrative modelling for stereotactic body radiotherapy in early-stage non-small cell lung cancer: clinical trial protocol of the MONDRIAN study
Response criteria in solid tumors (PERCIST/RECIST) and SUVmax in early-stage non-small cell lung cancer patients treated with stereotactic body radiotherapy
Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a multi-institutional phase I trial
Long-term survival and failure patterns in inoperable early-stage non-small cell lung cancer following stereotactic body radiotherapy: a single-institution retrospective study
Lung metastases treated with stereotactic body radiotherapy: the RSSearch® patient Registry’s experience
Comparison of quality of life after stereotactic body radiotherapy and surgery for early-stage prostate cancer
Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch® patient registry
Cost-effectiveness of stereotactic body radiotherapy versus conventional fractionated radiotherapy for medically inoperable, early-stage non-small cell lung cancer
Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer
Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer
Stereotactic ablative radiotherapy for early-stage lung cancer following double lung transplantation
Systematic review of economic evaluations on stereotactic ablative radiotherapy (SABR) compared to other radiotherapy techniques or surgical procedures for early-stage non-small cell lung cancer
Multi-omics integrative modelling for stereotactic body radiotherapy in early-stage non-small cell lung cancer: clinical trial protocol of the MONDRIAN study
Response criteria in solid tumors (PERCIST/RECIST) and SUVmax in early-stage non-small cell lung cancer patients treated with stereotactic body radiotherapy
Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a multi-institutional phase I trial
Long-term survival and failure patterns in inoperable early-stage non-small cell lung cancer following stereotactic body radiotherapy: a single-institution retrospective study
Lung metastases treated with stereotactic body radiotherapy: the RSSearch® patient Registry’s experience
Comparison of quality of life after stereotactic body radiotherapy and surgery for early-stage prostate cancer
Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch® patient registry
Cost-effectiveness of stereotactic body radiotherapy versus conventional fractionated radiotherapy for medically inoperable, early-stage non-small cell lung cancer
Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer
Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer
Stereotactic ablative radiotherapy for early-stage lung cancer following double lung transplantation
Systematic review of economic evaluations on stereotactic ablative radiotherapy (SABR) compared to other radiotherapy techniques or surgical procedures for early-stage non-small cell lung cancer
Multi-omics integrative modelling for stereotactic body radiotherapy in early-stage non-small cell lung cancer: clinical trial protocol of the MONDRIAN study
Response criteria in solid tumors (PERCIST/RECIST) and SUVmax in early-stage non-small cell lung cancer patients treated with stereotactic body radiotherapy
Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a multi-institutional phase I trial
Long-term survival and failure patterns in inoperable early-stage non-small cell lung cancer following stereotactic body radiotherapy: a single-institution retrospective study
Lung metastases treated with stereotactic body radiotherapy: the RSSearch® patient Registry’s experience